Gesynta Pharma has completed recruitment for its Phase 2 trial [...]
Gesynta Pharma has randomised half of the planned patients in [...]
Women’s health remains underfunded, underdiagnosed and undervalued — but a [...]
Gesynta Pharma has announced the second closing of its Series [...]